content

Novel Ovarian Cancer Treatment By GSK Approved In Singapore

The oral, once-daily Zejula (niraparib) tablet, a first-line and recurrent upkeep care for women with advanced epithelial high-grade ovarian, fallopian tube, or primary peritoneal...

The NHS Saves £1.2 Billion On Medications Over Three Years

The NHS has used its purchasing power to negotiate lower rates for dozens of hospital medications, saving taxpayers £1.2 billion in only three years...

Abbott India Confirms Drugs Are Fake And Not Their Make

Abbott informed yesterday, July 3rd, that there are several ways to tell if a customer's pack of Thyronorm is authentic or fake. The label...

World Biopharmaceutical Bioseparation Sector Aiming $20bn

Recent market analysis predicts that the international market for biopharmaceutical bioseparation systems, which is expected to be worth $13 billion in 2022, will increase...

FDA Recommends Omicron BA.4, 5 For COVID-19 Booster Dose

The Vaccines and Related Biological Products Advisory Panel of the U.S. Food and Drug Administration gathered on June 30th to evaluate whether a change to...

Omicron-Specific COVID-19 Vaccinations Can Act As Boosters

According to the European Medicines Agency and other international health agencies, coronavirus vaccinations that have been modified to incorporate the omicron variant strain can...

AstraZeneca Claims Research Success In Early Lung Cancer

The most prevalent kind of the disease, non-small cell lung cancer, has seen steady advancements in immunotherapies called checkpoint inhibitors during the past ten...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read